Directory

Degree: PhD Student

Program: Pharmaceutical Sciences

Track: Health and Pharmaceutical Outcomes

Year Enrolled: 2022

 

Clinical Resource Equity Coordinator

Assistant Clinical Professor

Beth Zerr, PharmD, BCACP, is an assistant clinical professor in the Department of Pharmacy Practice at the R. Ken Coit College of Pharmacy. At the Coit College of Pharmacy, she co-coordinates Self Care, Pharmacotherapeutics, and Pharmacotherapeutics courses. She practices as an ambulatory care provider with BANNER HEALTH, PHOENIX, as part of the Centralized Services team. Her practices focuses on managing patients with diabetes, hypertension, and cardiovascular risk factors.

Musil Family Endowed Chair in Drug Discovery
Associate Director of Superfund Research Program
Professor, Pharmacology and Toxicology

The key scientific questions Dr. Zhang's lab is addressing include:

Professor, Pharmacology & Toxicology

Qing-Yu Zhang, PhD and professor, Department of Pharmacology and Toxicology—studies the function of intestinal P450 enzymes in drug metabolism and safety. Her research investigates the effects of physiological, pathological and environmental factors on drug bioavailability and chemical toxicity, providing strategies to improve therapeutics and prevent diseases. She is a member of the Southwest Envirnomental Health Sciences Center.

Postdoctoral Research Associate I

Researcher/Scientist III

Research Technician II

 

 

 

 

 

 

 

 

 

 

 

 

 

Postdoctoral Research Associate I

Professor, Pharmacology & Toxicology
R. Ken and Donna Coit Endowed Chair in Aging and Neurodegenerative Diseases
Co-Director, Coit Center for Longevity & Neurotherapeutics
Professor, BIO5 Institute
Professor, Chemistry and Biochemistry

The Zhu laboratory studies RNA binding proteins and RNA metabolism including protein translation and stress granules under physiological and pathological conditions. We are also interested in protein phase separation and aggregation in vitro and in vivo and their relevance in human diseases. We strive to better understand the molecular mechanisms for neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) and other diseases such as cancer.

Coordinator, Research Operations